Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,904,229
+$868,684 QoQ
Shares Held
23,463
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#1,210
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLDERNESS INVESTMENTS CO holds $26,485,557 across 10 Drug Manufacturers - General names. ABBV ranks #1 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
23,463 | $5,904,229 | |
| 2 | MRK |
Merck & Co., Inc.
|
32,731 | $4,205,933 | |
| 3 | JNJ |
Johnson & Johnson
|
14,009 | $3,557,865 | |
| 4 | AMGN |
Amgen Inc
|
8,409 | $3,045,067 | |
| 5 | LLY |
ELI LILLY & Co
|
1,881 | $2,256,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,710 | $2,115,230 | |
| 7 | PFE |
Pfizer Inc
|
76,281 | $1,836,846 | |
| 8 | NVS |
Novartis AG
|
10,410 | $1,631,455 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,904,229 | 23,463 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,035,545 | 23,153 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,027,465 | 22,003 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,065,863 | 21,879 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,383,045 | 23,613 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,011,718 | 23,920 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,244,186 | 23,884 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,766,969 | 24,139 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,092,124 | 23,858 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,442,147 | 24,394 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,780,493 | 24,395 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,676,713 | 24,666 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,342,381 | 24,808 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,936,598 | 24,701 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,003,564 | 24,773 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,341,157 | 24,895 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,848,145 | 25,125 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,263,655 | 26,301 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,536,377 | 26,118 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,816,269 | 26,108 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,299,450 | 29,292 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $3,163,487 | 29,232 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,108,528 | 29,011 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,572,956 | 29,375 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,717,131 | 27,675 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,928,597 | 25,313 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||